14-day Premium Trial Subscription Try For FreeTry Free
$4.71
+0.0250 (+0.534%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.06 $5.34 Friday, 3rd May 2024 SVRA stock ended at $4.71. This is 0.534% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.33% from a day low at $4.66 to a day high of $4.81.
90 days $4.06 $5.70
52 weeks $1.83 $5.70

Historical Savara Inc prices

Date Open High Low Close Volume
Jun 28, 2016 $0.470 $0.480 $0.450 $0.472 3 336 506
Jun 27, 2016 $0.450 $0.479 $0.440 $0.464 3 509 971
Jun 24, 2016 $0.420 $0.455 $0.420 $0.450 3 304 002
Jun 23, 2016 $0.472 $0.472 $0.445 $0.456 2 987 055
Jun 22, 2016 $0.444 $0.477 $0.438 $0.451 6 250 519
Jun 21, 2016 $0.429 $0.444 $0.422 $0.438 4 128 720
Jun 20, 2016 $0.450 $0.453 $0.412 $0.429 6 051 824
Jun 17, 2016 $0.435 $0.436 $0.420 $0.428 1 665 987
Jun 16, 2016 $0.450 $0.450 $0.421 $0.430 4 184 122
Jun 15, 2016 $0.419 $0.455 $0.410 $0.430 6 890 505
Jun 14, 2016 $0.400 $0.415 $0.390 $0.411 4 611 193
Jun 13, 2016 $0.400 $0.402 $0.377 $0.391 3 784 348
Jun 10, 2016 $0.370 $0.390 $0.365 $0.378 2 214 259
Jun 09, 2016 $0.380 $0.416 $0.365 $0.371 3 409 679
Jun 08, 2016 $0.372 $0.379 $0.351 $0.360 2 298 062
Jun 07, 2016 $0.355 $0.390 $0.335 $0.380 6 080 485
Jun 06, 2016 $0.420 $0.423 $0.405 $0.412 3 379 522
Jun 03, 2016 $0.440 $0.440 $0.400 $0.417 3 621 179
Jun 02, 2016 $0.430 $0.445 $0.395 $0.430 3 782 341
Jun 01, 2016 $0.410 $0.449 $0.405 $0.415 7 955 159
May 31, 2016 $0.348 $0.390 $0.340 $0.386 3 650 159
May 27, 2016 $0.345 $0.350 $0.336 $0.336 2 021 453
May 26, 2016 $0.360 $0.369 $0.328 $0.340 4 179 754
May 25, 2016 $0.307 $0.350 $0.300 $0.340 5 128 054
May 24, 2016 $0.310 $0.314 $0.301 $0.306 1 531 031
Click to get the best stock tips daily for free!

About Savara Inc

Savara Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.... SVRA Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT